Exactly runner, its the consistency of the patches. They said that they didnt want to leave anything to chance in the phase 2/3 trials and although they could produce in-house the lower level of consistency could jeapordise the trials.
it's the right move. At the serious phase of development you dont want to be cutting corners. And the added advantage is that the patches can be used for commercial rollout almost immediately should pahse 2/3 trials prove successful.
- Forums
- ASX - By Stock
- AVE
- phosphagenics collaborates with 3m to develop
phosphagenics collaborates with 3m to develop , page-31
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $202 | 68.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
51 | 89002619 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 59770911 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
51 | 89002619 | 0.002 |
22 | 69095508 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 59770911 | 19 |
0.004 | 17122582 | 17 |
0.005 | 22833333 | 10 |
0.006 | 19255067 | 9 |
0.007 | 5722471 | 6 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online